For example, in breast and prostate cancer SFPQ appears to be an important driver of the cancer phenotype via post-transcriptional regulation of key genes such as oestrogen receptor α (ERα) and androgen receptor (AR), respectively [17, 20]. This evidence concerns the gene AR and prostate carcinoma.